DND DNDT Stock
DND Price Chart
DND DNDT Financial and Trading Overview
| DND stock price | 0.03 USD |
| Previous Close | 0.03 USD |
| Open | 0.03 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.03 - 0.03 USD |
| 52 Week Range | 0.02 - 0.1 USD |
| Volume | 20 USD |
| Avg. Volume | 82 USD |
| Market Cap | 9.97K USD |
| Beta (5Y Monthly) | -2.481 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.35 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
DNDT Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
DND Stock Price History
| Beta (5Y Monthly) | -2.481 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.1 USD |
| 52 Week Low | 0.02 USD |
| 50-Day Moving Average | 0.03 USD |
| 200-Day Moving Average | 0.04 USD |
DNDT Share Statistics
| Avg. Volume (3 month) | 82 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 0 |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2009 |
| Most Recent Quarter (mrq) | March 31, 2012 |
| Next Fiscal Year End | December 31, 2010 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 72.83% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -242.74% |
| Return on Equity (ttm) | -388.39% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -26166 USD |
| Diluted EPS (ttm) | -3.12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 50.69K USD |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | 360K USD |
| Total Debt/Equity (mrq) | 522.66 USD |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26166 USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of DND
| Country | United States |
| State | NY |
| City | New York |
| Address | 954 Lexington Avenue |
| ZIP | 10021 |
| Phone | 800 341 8940 |
| Website | N/A |
| Industry | Beverages-Non-Alcoholic |
| Sector(s) | Consumer Defensive |
| Full Time Employees | N/A |
DND Technologies, Inc., a holding company, produces and sells various specialty balms. It also manufactures and distributes pharmaceutical products, including Bioassaygen Gel to reduce wrinkles and promote natural skin re-genesis; Bioassaygen Cosmetic Mask for vanity applications; Bioassaygen Bio-Skin, a skin replacement bandage; and Bioassaygen Delivery Gel that accelerates natural skin re-genesis. The company distributes its products through wholesale, retail, and Internet. DND Technologies, Inc. was founded in 1997 and is based in New York, New York.
Q&A For DND Stock
What is a current DNDT stock price?
DND DNDT stock price today per share is 0.03 USD.
How to purchase DND stock?
You can buy DNDT shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for DND?
The stock symbol or ticker of DND is DNDT.
Which industry does the DND company belong to?
The DND industry is Beverages-Non-Alcoholic.
How many shares does DND have in circulation?
The max supply of DND shares is 470.11K.
What is DND Price to Earnings Ratio (PE Ratio)?
DND PE Ratio is now.
What was DND earnings per share over the trailing 12 months (TTM)?
DND EPS is -3.35 USD over the trailing 12 months.
Which sector does the DND company belong to?
The DND sector is Consumer Defensive.